US-based Dicerna Pharmaceuticals and Novo Nordisk have signed a deal worth up to around $607m to discover and develop drugs...
Read moreElsevier is working with the National Center for Toxicological Research (NCTR) at the FDA on a predictive drug-induced liver injury...
Read moreAquestive Therapeutics, a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, announced that Exservan...
Read moreBoth organisations have collaborated successfully on the event since 2016, when Rapid took on the annual event. The future cooperation...
Read moreThe global pharmaceutical company and service partner Inceptua Group and Bendalis GmbH – German manufacturer of generic oncology drugs and...
Read moreOakrum Pharma, LLC ("Oakrum"), in collaboration with SunGen Pharma, LLC ("SunGen"), announced the U.S. launch and commercial shipment of a...
Read moreA recently published human study from the University of Sydney, Australia, evaluated the efficacy of ABAlifeâ„¢ on glucose metabolism blood...
Read moreNovartis has pulled back the curtain on new Phase 2b data for its IgE/FceR1 pathway-blocking drug ligelizumab, showing that the...
Read moreNews that has taken the Pharmaceutical sector by storm, Amgen has announced positive results for 2 phase 3 BLINCYTO® (blinatumomab)...
Read moreRegeneron Pharmaceuticals, Inc. and Sanofi announced that the European Medicines Agency'sCommittee for Medicinal Products for Human Use (CHMP) has adopted...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.